HBEGF and dilated cardiomyopathy: Our previous work indicated that HB-EGF expression was increased with the development of dilated cardiomyopathy (DCM) in a cTnTr141w transgenic model, and treatment with ginsenoside Rb1 attenuated HB-EGF expression and heart fibrosis [30].